Changes to fees for human medicinal products and devices as of 1 January 2023
02-01-2023 | 08:00
With effect from 1 January 2023, the Medicines Evaluation Board (MEB) will be increasing the fees for authorisation applications, ...
Registering the continued use of antimycotics or antiprotozoal veterinary medicinal products exclusively intended for specific companion animals
29-12-2022 | 12:15
Prior to the introduction of the Veterinary Medicinal Products Regulation, antimycotics (antifungal agents) and antiprotozoal ...
Veterinary Medicinal Products Unit Fees for 2023 in revised Veterinary Medicinal Products Regulation 2022
29-12-2022 | 12:00
With effect from 1 January 2023, the Medicines Evaluation Board (MEB) will be increasing the fees. The fees of the Veterinary ...
New issue of Regulatory Science Magazine
07-12-2022 | 14:15
A significant portion of the potential anticancer medicines that reach the clinical phase do not make it to registration. This is ...
Amended procedure for sending, communicating and publishing letters and decisions
06-10-2022 | 16:30
The Veterinary Medicinal Products Unit has set in motion a number of changes to the sending, communicating and publishing letters ...
Form for specifying an e-mail address for receipt of digital decisions
16-08-2022 | 10:00
As from 1 October, the Veterinary Medicinal Products Unit will no longer send marketing authorisations in hard copy. We ask all ...